AACR 2019 highlights and updates

What’s happening at our booth?

You can come and meet our Digital Editor, Abi Sawyer, at booth #4438. If you’re interested in subscribing, submitting or contributing to BioTechniques, come and meet us and we will be more than happy to answer any of your questions. As if that wasn’t enough to entice you, we also have lots of goodies to give away, including some BioTechniques branded flash drives.

Follow what’s happening on Twitter at @MyBioTechniques

Video highlights

Sunday 31 March 2019 was the first exhibiting day of AACR19. Highlights from Sunday of AACR19 include speaking to Manel Esteller (University of Barcelona, Spain) about the importance of epigenetics in cancer research. There was also a key talk on digitizing clinical assessments for outcome predictions, involving Peter Kuhn (USC, CA, USA) and Jorge Nieva (Keck School of Medicine, CA, USA). This combination of physicist and physician provided interesting perspectives from different corners of scientific research.

On Monday 1 April 2019, our second day at AACR19, there was a lot of buzz surrounding the keynote talk by James P Allison (MD Anderson Cancer Center, TX, USA) on making science count for patients, with a focus on immuno-oncology. The AACR presidential run of Liz Jaffee (Johns Hopkins School of Medicine, MD, USA) officially ended, passing the baton on to Elaine Mardis (Washington University in St. Louis, MO, USA) for the coming year. The BioTechniques team also spoke to Andrea Califano (Columbia University, NY, USA), a pioneer in systems biology, about how these methods are being utilized to improve precision medicine.

AACR top news

Excess body weight before age 50 is associated with higher pancreatic cancer mortality risk

BMI before age 50 may be more strongly associated with pancreatic cancer risk than BMI at older ages.

Lynch syndrome vaccine could be on the horizon

A cancer-preventative vaccine has shown promise for Lynch syndrome in a preclinical study.

Study points the finger at a common SNP for stroke risk in cancer survivors

A common gene variant has been implicated in increased stroke risk for childhood cancer survivors following cranial radiation therapy.

New, high-throughput automated cell counter could give cellular analysis at a higher speed and accuracy

Nexcelom Bioscience (MA, USA) have announced the launch of their new automated cell counter, the CellacaTM MX.

Trending on Twitter